TransMedics Group, Inc. (TMDX)

Last Closing Price: 123.89 (2025-06-18)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

TransMedics Group, Inc. (TMDX) had Net Income of $25.68M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$143.54M
Net Income
$25.68M
$55.31M
$88.23M
$116.09M
$27.44M
$-0.77M
$26.68M
$26.68M
$25.68M
$25.68M
$25.68M
$25.68M
$27.44M
$33.58M
33.72M
39.91M
$0.76
$0.70
Balance Sheet Financials
$505.92M
$311.24M
$331.61M
$837.53M
$55.60M
$510.10M
$515.62M
$571.22M
$266.31M
$252.66M
$266.31M
33.83M
Cash Flow Statement Financials
$-2.85M
$-27.04M
$3.03M
$337.15M
$310.64M
$-26.51M
$8.96M
--
--
Fundamental Metrics & Ratios
9.10
--
--
0.66
1.92
61.47%
19.12%
19.12%
--
18.58%
17.89%
$-29.89M
--
--
--
0.17
1.27
1.01
89.05
9.64%
10.16%
3.07%
3.31%
$7.87
$-0.75
$-0.07